Skip to main content
PRESCIENT THERAPEUTICS LIMITED logo

PRESCIENT THERAPEUTICS LIMITED — Investor Relations & Filings

Ticker · PTX ISIN · AU000000PTX3 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,006 across all filing types
Latest filing 2020-05-25 Regulatory Filings
Country AU Australia
Listing ASX PTX

About PRESCIENT THERAPEUTICS LIMITED

https://ptxtherapeutics.com/

Prescient Therapeutics Limited is a clinical-stage oncology company focused on developing personalized medicine and innovative cancer treatments. The company leverages two primary technology pillars: modular cell therapies and targeted small molecule inhibitors. Its flagship OmniCAR platform is a universal, multi-arm CAR-T system designed to provide clinicians with enhanced control and flexibility over cell therapy treatments, addressing limitations such as antigen escape and toxicity. Complementing this is the CellPryme platform, which optimizes cell therapy performance through improved manufacturing and efficacy. Additionally, Prescient maintains a pipeline of targeted therapies, including PTX-100, a first-in-class prenylation inhibitor targeting the Ras pathway, and PTX-200, an AKT inhibitor. These programs aim to treat various hematological malignancies and solid tumors by addressing specific genetic drivers of cancer.

Recent filings

Filing Released Lang Actions
PTX signs next-gen anti-cancer platform from Penn & Oxford 6 pages 341.8KB
Regulatory Filings Classification · 95% confidence The document is a detailed announcement about Prescient Therapeutics licensing technology from the University of Pennsylvania and Oxford University to develop a universal CAR platform for cell therapy. It includes extensive background information, technical details about the OmniCAR platform, benefits, and future plans. It also mentions an upcoming investor call and provides contact information. There are no financial statements, quarterly or annual results, nor is this a transcript of a call or a regulatory filing about voting or management changes. The document is a corporate announcement focused on a licensing agreement and strategic development rather than a financial report or regulatory filing. It is not a brief factsheet or a presentation but a detailed announcement about a significant business development. Therefore, the most appropriate classification is a Regulatory Filing (RNS), as it is a general regulatory announcement that does not fit into other specific categories like capital update or M&A activity.
2020-05-25 English
Reinstatement to Official Quotation 1 page 88.2KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from ASX regarding the reinstatement of trading for Prescient Therapeutics Limited following a prior suspension. It mentions the lifting of suspension and references a prior announcement about a material license agreement. The document is short (714 characters) and serves as a regulatory update rather than a detailed report or financial statement. It does not contain financial data, management discussion, or detailed disclosures. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for general regulatory announcements and compliance notices.
2020-05-25 English
PTX universal CAR-T platform presentation 36 pages 2.3MB
Investor Presentation Classification · 95% confidence The document is a detailed presentation about a CAR-T platform technology, including background information, scientific explanation, clinical context, and company goals. It contains no financial statements, no regulatory filings, no voting results, no management changes, no legal proceedings, no audit information, and no earnings data. The content is educational and promotional, aimed at investors or stakeholders to explain the company's technology and strategy. The length is substantial (15,000 characters) and the style is consistent with an investor presentation. There is no indication that this is an annual report, interim report, or earnings release. Therefore, the document best fits the category of an Investor Presentation (IP).
2020-05-25 English
Voluntary Suspension 2 pages 181.7KB
Regulatory Filings Classification · 95% confidence The document is a market announcement regarding the voluntary suspension of trading of Prescient Therapeutics Limited's shares on the ASX. It references Listing Rule 17.2 and explains the suspension is pending a material licence agreement announcement. The document is short (2558 characters) and is an official notice rather than a financial report or detailed filing. It does not contain financial statements, audit information, or management discussion. It is clearly an announcement related to regulatory compliance and trading status, fitting the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2020-05-24 English
Pause in Trading 1 page 111.7KB
Regulatory Filings Classification · 95% confidence The document is a brief market release announcing a temporary pause in trading of the company's securities. It does not contain financial data, report content, or detailed information about company performance or governance. It is a regulatory announcement related to trading status, not a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-05-20 English
Trading Halt 2 pages 209.9KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from Prescient Therapeutics Limited regarding a trading halt requested pending a material license agreement announcement. It is a short notice about the trading halt and does not contain any financial data, report content, or detailed disclosures. It is an announcement related to market trading status rather than a financial report or detailed corporate filing. Therefore, it fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2020-05-20 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.